News

Below you will find links to various news.

For investor related and NASDAQ-regulated press releases, please go here.

Science Talk: Fast-tracking of a COVID-19 vaccine development

Join us for this Science Talk with Drs. Ali Salanti, Max M Søgaard, and Louise Leth Hefting on development of […]

ExpreS2ion is mentioned in Ingeniøren

Read full article here: https://ing.dk/artikel/danskere-vil-dyrke-coronavaccine-bananflueceller-232322

ExpreS2ion is mentioned in Nigerian Guardian

Read full article here: https://guardian.ng/interview/drug-shortage-imminent-if-coronavirus-epidemic-persists/

ExpreS2ion’s CSO Dr. Wian de Jongh to speak at the ISBiotech 8th Spring Meeting in Norfolk, Virginia, USA – March 5-7

ExpreS2ion Biotechnologies will be presenting at the ISBiotech 8th Spring Meeting taking place on March 5-7, 2018 in Norfolk, Virginia, […]

Media article about ExpreS2ion in Affärstidningen Näringsliv, a journal about Life Science in Greater Copenhagen

Expres2ion Biotechnologies is mentioned in the Swedish newspaper Affärstidningen Näringsliv, in the supplement section “Time to Unite – a Greater […]

Media article about ExpreS2ion in MedWatch, a Danish business journal about the Life Sciences industry

ExpreS2ion Biotechnologies is the topic of an article (in Danish) in the business journal MedWatch under the headline “ExpreS2ion-direktør efter […]

ExpreS2ion Biotechnologies Announces Research License Agreement with the University of Pennsylvania

Horsholm, Denmark, November 8, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]

Media article about ExpreS2ion in MedWatch, a Danish business journal about the Life Sciences industry

Expres2ion Biotechnologies is the topic of an article (in Danish) in the business journal MedWatch under the headline “Biotekselskab og […]

The Francis Crick Institute Renews the Research License Agreement with ExpreS2ion Biotechnologies

Horsholm, Denmark, June 26, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]

ExpreS2ion’s Chief Science Officer, Dr. Wian De Jongh, to Speak at World Biopharm Forum 2017 in Oxford, UK – June 27

Horsholm, Denmark, June 21, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]

ExpreS2ion’s Chief Executive Officer, Dr. Steen Klysner, Speaks at Investordagen in Aarhus, Denmark – June 13

Horsholm, Denmark, June 8, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]

Media article about ExpreS2ion in Affärstidningen Näringsliv, a journal about Life Science in Greater Copenhagen

Expres2ion Biotechnologies is mentioned in the Swedish newspaper Affärstidningen Näringsliv, in the supplement section “Time to Unite – a Greater […]

Interview with CEO Steen Klysner in Erhverv Nordsjælland

Expres2ion Biotechnologies is mentioned in the Danish newspaper Erhverv Nordsjælland. The article includes an interview with CEO Sten Klysner. The […]

ExpreS2ion’s Chief Scientific Officer, Dr. Wian de Jongh, to Speak at ISBiotech 7th Spring Meeting in Washington D.C. – March 6-8

Horsholm, Denmark, February 16, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]